KAS
RMD icon

Kemnay Advisory Services’s ResMed RMD Stock Holding History

Kemnay Advisory Services’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9K Buy
61
+3
+5% +$622 ﹤0.01% 997
2026
Q1 		$13K Buy
58
+5
+9% +$1.25K ﹤0.01% 905
2025
Q4 		$12.8K Buy
+53
New +$13.6K ﹤0.01% 684

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Kemnay Advisory Services's RMD Position: Q2 2026 in Review

Kemnay Advisory Services increased its ResMed (RMD) stake by 5.2% in Q2 2026, buying an estimated $622 and bringing the position to 61 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #997.

Kemnay Advisory Services first reported a position in RMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $13K in Q1 2026. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Kemnay Advisory Services held 61 shares of ResMed worth $11.9K as of Q2 2026.
  • Kemnay Advisory Services bought 3 ResMed shares in Q2 2026, an estimated $622.
  • ResMed made up ﹤0.01% of Kemnay Advisory Services's portfolio in Q2 2026, its #997 holding.
  • Kemnay Advisory Services first reported a position in ResMed in Q4 2025 and has held it in 3 quarters since.
  • Kemnay Advisory Services's ResMed position peaked at $13K in Q1 2026.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.